InvestorsHub Logo
Followers 23
Posts 1084
Boards Moderated 0
Alias Born 03/07/2013

Re: mick post# 570

Thursday, 01/21/2021 9:46:40 AM

Thursday, January 21, 2021 9:46:40 AM

Post# of 813
News out


https://vynetherapeutics.com/press-releases/vyne-therapeutics-announces-contract-execution-for-amzeeq-minocycline-and-zilxi-minocycline-with-major-pharmacy-benefit-management-pbm-company/





VYNE Therapeutics Announces Contract Execution for AMZEEQ® (minocycline) and ZILXI® (minocycline) with Major Pharmacy Benefit Management (PBM) Company
BRIDGEWATER, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced the execution of a contract with a major PBM for its novel AMZEEQ® (minocycline) topical foam, 4% and ZILXI® (minocycline) topical foam, 1.5%. AMZEEQ, the first topical minocycline to be approved by the U.S. Food and Drug Administration (“FDA”) for any condition, is indicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients 9 years of age and older. ZILXI is indicated for the treatment of inflammatory lesions of rosacea in adults and...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYNE News